RCE recce pharmaceuticals ltd

Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B, page-9

  1. 876 Posts.
    lightbulb Created with Sketch. 431
    Bpharma, you must get sick of being wrong.
    What is even a "lease photo"? Why would you need to take a photo to report on trial participant numbers? Nothing you say makes sense.

    Here is the actual trial info:
    https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381443

    Six participants were enrolled and commenced trial medication.
    Four participants received topical dosing to wounds as per protocol.
    One participant stopped treatment early.
    One participant switched to conventional antibiotic therapy.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
34.5¢
Change
-0.005(1.43%)
Mkt cap ! $99.76M
Open High Low Value Volume
34.0¢ 34.5¢ 33.5¢ $38.26K 112.6K

Buyers (Bids)

No. Vol. Price($)
3 10016 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 8605 1
View Market Depth
Last trade - 15.56pm 18/07/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.